AAAAAA
Results:
1-16
|
Results: 16
Authors:
Lush, RJ
Jones, SG
Haynes, AP
Citation: Rj. Lush et al., Advanced-stage, chemorefractory lymphocyte-predominant Hodgkin's disease: Long-term follow-up of allografting and monoclonal antibody therapy, BR J HAEM, 114(3), 2001, pp. 734-735
Authors:
Rawstron, AC
Kennedy, B
Evans, PAS
Davies, FE
Richards, SJ
Haynes, AP
Russell, NH
Hale, G
Morgan, GJ
Jack, AS
Hillmen, P
Citation: Ac. Rawstron et al., Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome andcan be used to optimize therapy, BLOOD, 98(1), 2001, pp. 29-35
Authors:
Haynes, AP
Citation: Ap. Haynes, What is the role of high-dose therapy in the management of lymphoma?, CL ONCOL-UK, 12(2), 2000, pp. 87-92
Authors:
Byrne, JL
Stainer, C
Cull, G
Haynes, AP
Bessell, EM
Hale, G
Waldmann, H
Russell, NH
Citation: Jl. Byrne et al., The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia, BONE MAR TR, 25(4), 2000, pp. 411-417
Authors:
Cull, GM
Haynes, AP
Byrne, JL
Carter, GI
Miflin, G
Rebello, P
Hale, G
Waldmann, H
Russell, NH
Citation: Gm. Cull et al., Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity, BR J HAEM, 108(4), 2000, pp. 754-760
Authors:
Byrne, JL
Beshti, H
Clark, D
Ellis, I
Haynes, AP
Das-Gupta, E
Russell, NH
Citation: Jl. Byrne et al., Induction of remission after donor leucocyte infusion for the treatment ofrelapsed chronic idiopathic myelofibrosis following allogeneic transplantation: evidence for a 'graft vs. myelofibrosis' effect, BR J HAEM, 108(2), 2000, pp. 430-433
Authors:
Borgani, S
da Costa, LN
Zehavi, I
Giovanelli, R
Haynes, AP
Freudling, W
Wegner, G
Salzer, JJ
Citation: S. Borgani et al., Correlation analysis of SFI peculiar velocities, ASTRONOM J, 119(1), 2000, pp. 102-110
Authors:
Daniels, I
Fletcher, J
Haynes, AP
Citation: I. Daniels et al., Role of p38 in the priming of human neutrophils by peritoneal dialysis effluent, CL DIAG LAB, 6(6), 1999, pp. 878-884
Authors:
Byrne, JL
Dasgupta, E
Pallis, M
Turzanski, J
Forman, K
Mitchell, D
Haynes, AP
Russell, NH
Citation: Jl. Byrne et al., Early allogeneic transplantation for refractory or relapsed acute leukaemia following remission induction with FLAG, LEUKEMIA, 13(5), 1999, pp. 786-791
Authors:
McQuaker, IG
Haynes, AP
Stainer, C
Byrne, JL
Russell, NH
Citation: Ig. Mcquaker et al., Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34(+) cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease, BONE MAR TR, 24(7), 1999, pp. 715-722
Authors:
Cull, GM
Carter, GI
Timms, JM
Thomson, BJ
Russell, NH
Haynes, AP
Citation: Gm. Cull et al., Low incidence of human herpesvirus 8 in stem cell collections from myelomapatients, BONE MAR TR, 23(8), 1999, pp. 759-761
Authors:
Miflin, G
Stainer, CJ
Carter, GI
Byrne, JL
Haynes, AP
Russell, NH
Citation: G. Miflin et al., Comparative serial quantitative measurements of chimaerism following unmanipulated allogeneic transplantation of peripheral blood stem cells and bonemarrow, BR J HAEM, 107(2), 1999, pp. 429-440
Authors:
Roe, SD
Cassidy, MJD
Haynes, AP
Byrne, JL
Citation: Sd. Roe et al., Heparin-induced thrombocytopenia (HIT) and thrombosis in a haemodialysis-dependent patient with systemic vasculitis, NEPH DIAL T, 13(12), 1998, pp. 3226-3229
Authors:
Russell, NH
McQuaker, G
Stainer, C
Byrne, JL
Haynes, AP
Citation: Nh. Russell et al., Stem cell mobilisation in lymphoproliferative diseases, BONE MAR TR, 22(10), 1998, pp. 935-940
Authors:
McQuaker, IG
Haynes, AP
Russell, NH
Citation: Ig. Mcquaker et al., G-CSF dosage and scheduling following autologous PBSC transplantation, BONE MAR TR, 22(10), 1998, pp. 1027-1028
Authors:
Byrne, JL
Carter, GI
Davies, JM
Haynes, AP
Russell, NH
Cross, NCP
Citation: Jl. Byrne et al., A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical course, BR J HAEM, 103(3), 1998, pp. 791-794
Risultati:
1-16
|